Bextra Plaintiffs Blast Summary Judgment Motion
As Pfizer Inc. geared up for the first trials in multidistrict litigation over its arthritis drugs Celebrex and Bextra, plaintiffs rebuffed the drug company's bid for summary judgment and defended their...To view the full article, register now.
Already a subscriber? Click here to view full article